MicroTech Medical (Hangzhou) Co., Ltd.
HKSE: 2235.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Pan Zheng
- Employees
- 678
- Headquarters
- Hangzhou, China
- IPO year
- 2021
- Market cap
- HK$3.2B
- Website
- https://www.microtechmd.com
Loading 2235…
Loading profile data…Frequently asked questions about 2235
What does MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK) do?
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables in the People's Republic of China and internationally. Its products include Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems,...
Where does 2235.HK trade?
MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK) trades on the Hong Kong Stock Exchange.
What sector is 2235.HK in?
MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of MicroTech Medical (Hangzhou) Co., Ltd.?
Pan Zheng is the chief executive officer of MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK).
Where is MicroTech Medical (Hangzhou) Co., Ltd. headquartered?
MicroTech Medical (Hangzhou) Co., Ltd. is headquartered in China.
Does 2235.HK pay a dividend?
MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 2235.HK go public?
MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK) completed its initial public offering in 2021.